Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial

Itch Severity and Quality of Life in Patients with Pruritus: Preliminary Validity of a Danish Adaptation of the Itch Severity Scale

(2013) R Zachariae et al.   ACTA DERMATO-VENEREOLOGICA

Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies

(2013) P.L. Mattei et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

(2012) Craig Leonardi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Affective and Sensory Dimensions of Pruritus Severity: Associations with Psychological Symptoms and Quality of Life in Psoriasis Patients

(2008) R Zachariae et al.   ACTA DERMATO-VENEREOLOGICA

The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab

(2008) Kristian Reich et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis

(2008) Dennis A. Revicki et al.   DERMATOLOGY